Two Thousand Seven Highlights
Quarter Two Highlights
Signed a three-year agreement with Premier, Inc., the nation’s largest healthcare purchasing network, enabling Premier members to purchase the entire Beckman Coulter suite of clinical diagnostics products for automation, routine chemistry, immunoassay, integrated work cells, hemostasis and hematology.
Commercialized the company’s newest immunoassay system, the UniCel® DxI 600, with a throughput of 200 tests per hour. The DxI 600 provides many of the benefits of the company’s market leading, 400-test-per-hour system, the DxI 800, in a smaller footprint designed for mid- to large-sized hospital laboratories.
Received a grant from the Imperial College of London to develop a simple, affordable point-of-care (POC) test for monitoring CD4 lymphocytes in patients with HIV/AIDS. This important test is needed in resource-poor countries like sub-Saharan Africa to assess prognosis and aid in treatment decisions for HIV/AIDS patients.